These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 23624135

  • 1. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L, Lentjes E, Hermus A, Zelissen P.
    Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
    [Abstract] [Full Text] [Related]

  • 2. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
    Ross IL, Lacerda M, Pillay TS, Blom DJ, Johannsson G, Dave JA, Levitt NS, Haarburger D, van der Walt JS.
    Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
    [Abstract] [Full Text] [Related]

  • 3. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K, Thorsen TE, Husebye ES.
    J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
    [Abstract] [Full Text] [Related]

  • 4. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
    Ross IL, Levitt NS, Van der Walt JS, Schatz DA, Johannsson G, Haarburger DH, Pillay TS.
    Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
    [Abstract] [Full Text] [Related]

  • 5. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
    Gagliardi L, Nenke MA, Thynne TR, von der Borch J, Rankin WA, Henley DE, Sorbello J, Inder WJ, Torpy DJ.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
    [Abstract] [Full Text] [Related]

  • 6. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
    Oksnes M, Björnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, Broman JE, Triebner K, Kämpe O, Hulting AL, Bensing S, Husebye ES, Løvås K.
    J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
    [Abstract] [Full Text] [Related]

  • 7. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N, Gilbert R, Wirth A, Casley D, Jerums G.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS, Rushworth RL, Clifton PM, Torpy DJ.
    BMC Endocr Disord; 2015 Oct 24; 15():61. PubMed ID: 26500000
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
    Ekman B, Blomgren J, Andersson PO, Carlsson M, Arnqvist HJ.
    Horm Metab Res; 2010 Dec 24; 42(13):961-6. PubMed ID: 20925018
    [Abstract] [Full Text] [Related]

  • 14. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V, Betterle C, Frigo AC, Zaccariotto V, Zaninotto M, De Caneva E, Lucato P, Gomiero W, Garelli S, Sabbadin C, Salvà M, Costa MD, Boscaro M, Luisetto G.
    Endocrine; 2018 Feb 24; 59(2):319-329. PubMed ID: 28795340
    [Abstract] [Full Text] [Related]

  • 15. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S.
    Clin Endocrinol (Oxf); 2015 Jul 24; 83(1):28-35. PubMed ID: 25400085
    [Abstract] [Full Text] [Related]

  • 16. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes.
    Riedel M, Wiese A, Schürmeyer TH, Brabant G.
    Exp Clin Endocrinol; 1993 Jul 24; 101(2):106-11. PubMed ID: 8405139
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F, Barbot M, Lizzul L, Selmin E, Saller A, Albiger N, Betterle C, Boscaro M, Scaroni C.
    Clin Endocrinol (Oxf); 2018 Feb 24; 88(2):201-208. PubMed ID: 28973827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.